BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29710543)

  • 1. Molecular mechanism of Poria cocos combined with oxaliplatin on the inhibition of epithelial-mesenchymal transition in gastric cancer cells.
    Wang N; Liu D; Guo J; Sun Y; Guo T; Zhu X
    Biomed Pharmacother; 2018 Jun; 102():865-873. PubMed ID: 29710543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poria Acid, Triterpenoids Extracted from
    Wang H; Luo Y; Chu Z; Ni T; Ou S; Dai X; Zhang X; Liu Y
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphA2 affects the sensitivity of oxaliplatin by inducing EMT in oxaliplatin-resistant gastric cancer cells.
    Wen Q; Chen Z; Chen Z; Chen J; Wang R; Huang C; Yuan W
    Oncotarget; 2017 Jul; 8(29):47998-48011. PubMed ID: 28624791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistin-Like Molecule-β Promotes Invasion and Migration of Gastric Carcinoma Cells.
    Jiang R; Zhao C; Wang X; Wang S; Sun X; Tian Y; Song W
    Med Sci Monit; 2016 Mar; 22():937-42. PubMed ID: 27001185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
    Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q
    Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetastatic effects of Celastrus orbiculatus on human gastric adenocarcinoma by inhibiting epithelial-mesenchymal transition and NF-κB/snail signaling pathway.
    Zhu Y; Liu Y; Qian Y; Dai X; Yang L; Chen J; Guo S; Hisamitsu T
    Integr Cancer Ther; 2015 May; 14(3):271-81. PubMed ID: 25722220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
    Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW
    Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition.
    Zhou HM; Dong TT; Wang LL; Feng B; Zhao HC; Fan XK; Zheng MH
    World J Gastroenterol; 2012 Jun; 18(21):2640-8. PubMed ID: 22690072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
    Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells.
    Yuan D; Xia H; Zhang Y; Chen L; Leng W; Chen T; Chen Q; Tang Q; Mo X; Liu M; Bi F
    Int J Oncol; 2014 Dec; 45(6):2430-8. PubMed ID: 25200917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.
    Xie R; Wang X; Qi G; Wu Z; Wei R; Li P; Zhang D
    Tumour Biol; 2016 Sep; 37(9):12049-12059. PubMed ID: 27179963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
    Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CD133 promotes the invasion and metastasis of gastric cancer via epithelial-mesenchymal transition].
    Cai C; Yu JW; Wu JG; Lu RQ; Ni XC; Wang SL; Jiang BJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):662-7. PubMed ID: 23888452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
    Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
    Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway.
    Zang MD; Hu L; Fan ZY; Wang HX; Zhu ZL; Cao S; Wu XY; Li JF; Su LP; Li C; Zhu ZG; Yan M; Liu BY
    J Transl Med; 2017 Feb; 15(1):52. PubMed ID: 28241766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of β-asarone on Epithelial-Mesenchymal Transition of Gastric Cancer in Nude Mice].
    Wu J; Zou X; Chen M; Liu SL; Zhang XX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2017 Apr; 37(4):443-447. PubMed ID: 30650503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.